Sumi Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
Sumi Kim has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Jaerang Rho
Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon, Korea
3 shared publications - Bongjin Shin
Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon 34134, Korea
1 shared publication - Dulshara Sachini Amarasekara
University of Colombo
1 shared publication - Eui-Soon Park
Howard Hughes Medical Institute , Chevy Chase, MD
1 shared publication Eunkyoung Shin
Seoul National University of Science and Technology, Seoul, South Korea
1 shared publicationGyu-Bong Yu
Department of Obstetrics and Gynecology, Dankook University College of Medicine, Cheonan, Korea
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 11 March 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 2851
Regulation of Osteoblast Differentiation by Cytokine Networks
Osteoblasts, which are bone-forming cells, play pivotal roles in bone modeling and remodeling. Osteoblast differentiation, also known as osteoblastogenesis, is orchestrated by transcription factors, such as runt-related transcription factor 1/2, osterix, activating transcription factor 4, special AT-rich sequence-binding protein 2 and activator protein-1. Osteoblastogenesis is regulated by a network of cytokines under physiological and pathophysiological conditions. Osteoblastogenic cytokines, such as interleukin-10 (IL-10), IL-11, IL-18, interferon-γ (IFN-γ), cardiotrophin-1 and oncostatin M, promote osteoblastogenesis, whereas anti-osteoblastogenic cytokines, such as tumor necrosis factor-α (TNF-α), TNF-β, IL-1α, IL-4, IL-7, IL-12, IL-13, IL-23, IFN-α, IFN-β, leukemia inhibitory factor, cardiotrophin-like cytokine, and ciliary neurotrophic factor, downregulate osteoblastogenesis. Although there are gaps in the body of knowledge regarding the interplay of cytokine networks in osteoblastogenesis, cytokines appear to be potential therapeutic targets in bone-related diseases. Thus, in this study, we review and discuss our osteoblast, osteoblast differentiation, osteoblastogenesis, cytokines, signaling pathway of cytokine networks in osteoblastogenesis.
- 11 March 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (6) , 2851
Top Cited PapersOpen AccessRegulation of Osteoblast Differentiation by Cytokine Networks
Osteoblasts, which are bone-forming cells, play pivotal roles in bone modeling and remodeling. Osteoblast differentiation, also known as osteoblastogenesis, is orchestrated by transcription factors, such as runt-related transcription factor 1/2, osterix, activating transcription factor 4, special AT-rich sequence-binding protein 2 and activator protein-1. Osteoblastogenesis is regulated by a network of cytokines under physiological and pathophysiological conditions. Osteoblastogenic cytokines, such as interleukin-10 (IL-10), IL-11, IL-18, interferon-γ (IFN-γ), cardiotrophin-1 and oncostatin M, promote osteoblastogenesis, whereas anti-osteoblastogenic cytokines, such as tumor necrosis factor-α (TNF-α), TNF-β, IL-1α, IL-4, IL-7, IL-12, IL-13, IL-23, IFN-α, IFN-β, leukemia inhibitory factor, cardiotrophin-like cytokine, and ciliary neurotrophic factor, downregulate osteoblastogenesis. Although there are gaps in the body of knowledge regarding the interplay of cytokine networks in osteoblastogenesis, cytokines appear to be potential therapeutic targets in bone-related diseases. Thus, in this study, we review and discuss our osteoblast, osteoblast differentiation, osteoblastogenesis, cytokines, signaling pathway of cytokine networks in osteoblastogenesis.
- Open Access
- 20 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4) , 2097
Pax5 Negatively Regulates Osteoclastogenesis through Downregulation of Blimp1
Paired box protein 5 (Pax5) is a crucial transcription factor responsible for B-cell lineage specification and commitment. In this study, we identified a negative role of Pax5 in osteoclastogenesis. The expression of Pax5 was time-dependently downregulated by receptor activator of nuclear factor kappa B (RANK) ligand (RANKL) stimulation in osteoclastogenesis. Osteoclast (OC) differentiation and bone resorption were inhibited (68.9% and 48% reductions, respectively) by forced expression of Pax5 in OC lineage cells. Pax5 led to the induction of antiosteoclastogenic factors through downregulation of B lymphocyte-induced maturation protein 1 (Blimp1). To examine the negative role of Pax5 in vivo, we generated Pax5 transgenic (Pax5Tg) mice expressing the human Pax5 transgene under the control of the tartrate-resistant acid phosphatase (TRAP) promoter, which is expressed mainly in OC lineage cells. OC differentiation and bone resorption were inhibited (54.2–76.9% and 24.0–26.2% reductions, respectively) in Pax5Tg mice, thereby contributing to the osteopetrotic-like bone phenotype characterized by increased bone mineral density (13.0–13.6% higher), trabecular bone volume fraction (32.5–38.1% higher), trabecular thickness (8.4–9.0% higher), and trabecular number (25.5–26.7% higher) and decreased trabecular spacing (9.3–10.4% lower) compared to wild-type control mice. Furthermore, the number of OCs was decreased (48.8–65.3% reduction) in Pax5Tg mice. These findings indicate that Pax5 plays a negative role in OC lineage specification and commitment through Blimp1 downregulation. Thus, our data suggest that the Pax5–Blimp1 axis is crucial for the regulation of RANKL-induced osteoclastogenesis.
- 20 February 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (4) , 2097
Open AccessPax5 Negatively Regulates Osteoclastogenesis through Downregulation of Blimp1
Paired box protein 5 (Pax5) is a crucial transcription factor responsible for B-cell lineage specification and commitment. In this study, we identified a negative role of Pax5 in osteoclastogenesis. The expression of Pax5 was time-dependently downregulated by receptor activator of nuclear factor kappa B (RANK) ligand (RANKL) stimulation in osteoclastogenesis. Osteoclast (OC) differentiation and bone resorption were inhibited (68.9% and 48% reductions, respectively) by forced expression of Pax5 in OC lineage cells. Pax5 led to the induction of antiosteoclastogenic factors through downregulation of B lymphocyte-induced maturation protein 1 (Blimp1). To examine the negative role of Pax5 in vivo, we generated Pax5 transgenic (Pax5Tg) mice expressing the human Pax5 transgene under the control of the tartrate-resistant acid phosphatase (TRAP) promoter, which is expressed mainly in OC lineage cells. OC differentiation and bone resorption were inhibited (54.2–76.9% and 24.0–26.2% reductions, respectively) in Pax5Tg mice, thereby contributing to the osteopetrotic-like bone phenotype characterized by increased bone mineral density (13.0–13.6% higher), trabecular bone volume fraction (32.5–38.1% higher), trabecular thickness (8.4–9.0% higher), and trabecular number (25.5–26.7% higher) and decreased trabecular spacing (9.3–10.4% lower) compared to wild-type control mice. Furthermore, the number of OCs was decreased (48.8–65.3% reduction) in Pax5Tg mice. These findings indicate that Pax5 plays a negative role in OC lineage specification and commitment through Blimp1 downregulation. Thus, our data suggest that the Pax5–Blimp1 axis is crucial for the regulation of RANKL-induced osteoclastogenesis.
- Open Access
- 1 January 2021
- Published by Elsevier in Molecules and Cells
- Vol. 44 (1) , 1-12
T-Cell Death-Associated Gene 51 Is a Novel Negative Regulator of PPARγ That Inhibits PPARγ-RXRα Heterodimer Formation in Adipogenesis
Sumi Kim, Nari Lee, Eui-Soon Park, Hyeongseok Yun, Tae-Uk Ha, Hyoeun Jeon, Jiyeon Yu, Seunga Choi, Bongjin Shin, Jungeun Yu, Sang Dal Rhee, Yongwon Choi, and Jaerang Rho. Mol. Cells 2021;44:1-12. https://doi.org/10.14348/molcells.2020.0143
- 1 January 2021
- Published by Elsevier in Molecules and Cells
- Vol. 44 (1) , 1-12
Open AccessT-Cell Death-Associated Gene 51 Is a Novel Negative Regulator of PPARγ That Inhibits PPARγ-RXRα Heterodimer Formation in Adipogenesis
Sumi Kim, Nari Lee, Eui-Soon Park, Hyeongseok Yun, Tae-Uk Ha, Hyoeun Jeon, Jiyeon Yu, Seunga Choi, Bongjin Shin, Jungeun Yu, Sang Dal Rhee, Yongwon Choi, and Jaerang Rho. Mol. Cells 2021;44:1-12. https://doi.org/10.14348/molcells.2020.0143
- Open Access
- 1 January 2016
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 59 (5) , 403-406
Aortic dissection accompanied by preeclampsia in a postpartum young woman
Park JW, et al. Obstet Gynecol Sci. 2016 Sep;59(5):403-406. https://doi.org/10.5468/ogs.2016.59.5.403
- 1 January 2016
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 59 (5) , 403-406
Open AccessAortic dissection accompanied by preeclampsia in a postpartum young woman
Park JW, et al. Obstet Gynecol Sci. 2016 Sep;59(5):403-406. https://doi.org/10.5468/ogs.2016.59.5.403
- 1 October 2011
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 318-319
Physicochemical and biological characterization of hyaluronic acid-poly(ethylene oxide) hydrogel
Hydrogel is a cross-linked, 3-D network of polymers absorbing and retaining large amount water. It has been employed as diverse forms in tissue engineering and cell therapy, including micro- or nano- particles, films and coatings. Hyaluronic acid (HA), consisting of disaccharide units of glucuronic acid and N-acetylglucosamine, is major components of synovial fluid and a biodegradable polysaccharide, which is degraded by hyaluronidases. A HA-based hydrogel was synthesized by employing HA and poly(ethylene oxide) (PEO) after chemical modification of HA. Its physicochemical characterization was evlautaed by observing behaviors of gelation, rheology, swelling and drug release. In vitro biocompatibility and cell cytoxicity of the HA-PEO hydrogel were also done. Their results showed excellent potential as a scaffold for tissue engineering.
- 1 October 2011
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 318-319
Physicochemical and biological characterization of hyaluronic acid-poly(ethylene oxide) hydrogel
Hydrogel is a cross-linked, 3-D network of polymers absorbing and retaining large amount water. It has been employed as diverse forms in tissue engineering and cell therapy, including micro- or nano- particles, films and coatings. Hyaluronic acid (HA), consisting of disaccharide units of glucuronic acid and N-acetylglucosamine, is major components of synovial fluid and a biodegradable polysaccharide, which is degraded by hyaluronidases. A HA-based hydrogel was synthesized by employing HA and poly(ethylene oxide) (PEO) after chemical modification of HA. Its physicochemical characterization was evlautaed by observing behaviors of gelation, rheology, swelling and drug release. In vitro biocompatibility and cell cytoxicity of the HA-PEO hydrogel were also done. Their results showed excellent potential as a scaffold for tissue engineering.